Samsung Bioepis Co. Ltd. v Janssen Biotech, Inc.

Federal Court No. T-2324-23

We represented Janssen.

This case related to Janssen’s patent covering its blockbuster drug STELARA.

The notice of discontinuance was filed October 2, 2025